In the tumor microenvironment, membrane-bound NKG2D ligands (e.g., MICA/MICB, ULBP) activate γδ T cells, but soluble NKG2D ligands inhibit NK and CD8+ T-cell functions by downregulating NKG2D. This evidence concerns the gene KLRK1 and neoplasm.